Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Multiple FMT for Severe CDI
NCT03427229Phase 2Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Clostridium difficile infection (CDI), sponsored by Università Cattolica del Sacro Cuore. Started Mar 2016; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT03427229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427229.